E-LIB Suche - Ergebnisse für: Stockhammer, G.

1

P13.06.A RADIOMIC FEATURES FOR RISK-STRATIFICATION IN PATIE..:

Heugenhauser, J ; Herbst, S ; Drucks, T...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii101-ii102 , 2023

Link: https://doi.org/10.1093/..

2

OS06.7.A SOMATOSTATIN RECEPTOR SUBTYPE EXPRESSION AND RADIO..:

Iglseder, S ; Iglseder, A ; Beliveau, V...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii18-ii18 , 2023

Link: https://doi.org/10.1093/..

3

OS06.6.A Real-World Pattern of Care Study on Glioblastoma i..:

Oberndorfer, S ; Woehrer, A ; Borkovec, M...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii14-ii15 , 2022

Link: https://doi.org/10.1093/..

4

OS05.4.A Do neurocognitive deficits explain the differences..:

Oort, Q ; Dirven, L ; Sikkes, S...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii7-ii7 , 2021

Link: https://doi.org/10.1093/..

5

Intravascular large B-cell lymphoma mimicking central nervo..:

Fischer, M. ; Iglseder, S. ; Grams, A....
Human Pathology: Case Reports. 8 (2017) - p. 3-8 , 2017

Link: https://doi.org/10.1016/..

6

Serious tumor seeding after brainstem biopsy and its treatm..:

Pinggera, D. ; Kvitsaridtze, I. ; Stockhammer, G....
Acta Neurochirurgica. 159 (2017) 4 - p. 751-754 , 2017

Link: https://doi.org/10.1007/..

7

Non-convulsive status epilepticus with negative phenomena—A..:

Hametner, E. ; Unterberger, I. ; Lutterotti, A....
Seizure. 25 (2015) - p. 49-51 , 2015

Link: https://doi.org/10.1016/..

8

NI-62 * DCE-MRI DISCRIMINATES BETWEEN RESPONDER AND NON-RES..:

Nowosielski, M. ; Kremser, C. ; Schocke, M....
Neuro-Oncology. 16 (2014) suppl 5 - p. v152-v152 , 2014

Link: https://doi.org/10.1093/..

9

O9.08 * END OF LIFE CARE IN HIGH-GRADE GLIOMA PATIENTS IN T..:

Koekkoek, J. A. F. ; Dirven, L. ; Reijneveld, J. C....
Neuro-Oncology. 16 (2014) suppl 2 - p. ii22-ii22 , 2014

Link: https://doi.org/10.1093/..

10

O7.04 * DCE-MRI DISCRIMINATES BETWEEN RESPONDER AND NON-RES..:

Nowosielski, M. ; Kremser, C. ; Schocke, M....
Neuro-Oncology. 16 (2014) suppl 2 - p. ii15-ii16 , 2014

Link: https://doi.org/10.1093/..

11

End of life care in high-grade glioma patients in three Eur..:

Koekkoek, J. A. F. ; Dirven, L. ; Reijneveld, J. C....
Journal of Neuro-Oncology. 120 (2014) 2 - p. 303-310 , 2014

Link: https://doi.org/10.1007/..

12

Symptoms and medication management in the end of life phase..:

Koekkoek, J. A. F. ; Dirven, L. ; Sizoo, E. M....
Journal of Neuro-Oncology. 120 (2014) 3 - p. 589-595 , 2014

Link: https://doi.org/10.1007/..

13

P06.04 * PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) WITH ..:

Iglseder, S. ; Nowosielski, M. ; Muigg, A....
Neuro-Oncology. 16 (2014) suppl 2 - p. ii45-ii45 , 2014

Link: https://doi.org/10.1093/..

14

Response to "Reply to [18F]-fluoro-ethyl-L-tyrosine PET: a ..:

Hutterer, M. ; Nowosielski, M. ; Putzer, D....
Neuro-Oncology. 15 (2013) 7 - p. 814-815 , 2013

Link: https://doi.org/10.1093/..

15

Glioma Biomarker Discovery by Mass Spectrometry (P06.001):

Dekker, L. ; Kheirollahi, M. ; Stockhammer, G...
Neurology. 78 (2012) Meeting Abstracts 1 - p. P06.001-P06.001 , 2012

Link: https://doi.org/10.1212/..